Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy

Autor: Ascensión López-Díaz de Cerio, Iñigo Perez-Estenaga, Susana Inoges, Gloria Abizanda, Juan José Gavira, Eduardo Larequi, Enrique Andreu, Saray Rodriguez, Ana Gloria Gil, Verónica Crisostomo, Francisco Miguel Sanchez-Margallo, Javier Bermejo, Blanca Jauregui, Lluis Quintana, Francisco Fernández-Avilés, Beatriz Pelacho, Felipe Prósper

Publikováno v: Pharmaceutics, Vol 13, Iss 8, p 1269 (2021)

The use of allogeneic adipose-derived mesenchymal stromal cells (alloADSCs) represents an attractive approach for treating myocardial infarction (MI). Furthermore, adding a natural support improves alloADSCs engraftment and survival in heart tissues,

Externí odkaz: https://doaj.org/article/eaac39e0786e444191d04b467dcd7b96

Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy.

Autor: López-Díaz de Cerio, Ascensión^1,2 (AUTHOR) aslopez@unav.es, Perez-Estenaga, Iñigo³ (AUTHOR) iperez.27@alumni.unav.es, Inoges, Susana^1,2 (AUTHOR) jjgavira@unav.es, Abizanda, Gloria^2,3 (AUTHOR) elardanaz@unav.es, Gavira, Juan José^2,4 (AUTHOR), Larequi, Eduardo³ (AUTHOR) srodrigu@unav.es, Andreu, Enrique^1,2 (AUTHOR) andreu@unav.es, Rodriguez, Saray³ (AUTHOR), Gil, Ana Gloria⁵ (AUTHOR) agil@unav.es, Crisostomo, Verónica^6,7 (AUTHOR) javier.bermejo@salud.madrid.org, Sanchez-Margallo, Francisco Miguel^6,7 (AUTHOR) faviles@redcardiovascular.com, Bermejo, Javier^7,8,9 (AUTHOR), Jauregui, Blanca¹⁰ (AUTHOR) JaureguiB@viscofan.com, Quintana, Lluis¹¹ (AUTHOR) quintana@bio.viscofan.com, Fernández-Avilés, Francisco^7,8,9 (AUTHOR), Pelacho, Beatriz^2,3 (AUTHOR) bpelacho@unav.es, Prósper, Felipe^1,2,3 (AUTHOR) bpelacho@unav.es

Publikováno v: Pharmaceutics. Aug2021, Vol. 13 Issue 8, p1269. 1p.